Exo mdx

@UCtBsnGv76JNLlY43vMvSHaQ - 982 subscribers

The Exo mdx test is an independent risk assessment of clinically significant prostate cancer to assist biopsy decision with in-office or at-home collection available. Exo mdx is independent of DRE, PSA, and other standard of care features validated with Level 1 evidence and covered by Medicare and many commercial providers. Exosome Diagnostics, a subsidiary of mdxhealth, commercializes non-invasive biomarker diagnostic solutions to benefit clinical outcomes, patients and physicians alike.